Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

PSNC’s advice for community pharmacies on bank holiday for queen’s state funeral

As 19th September has been declared a bank holiday for Her Majesty Queen Elizabeth II’s state funeral, the Pharmaceutical Services Negotiating Committee (PSNC) has advised that there is a need for some pharmacies to remain open for public interest.

NHS England has discussed with PSNC how this will impact community pharmacy and is in the process of sending a letter to all contractors, setting out the above and requesting that they work with their local NHS England team to help plan arrangements for pharmaceutical provision in the area on the 19th of September.


In considering arrangements for the 19th, contractors are encouraged to:

  1. Consider the needs of their patients, including any specific clinical needs, since patients have little time to prepare. In particular, patients who collect controlled drugs in instalments should be considered, noting the use of approved Home Office wording on prescriptions (see further information on our Controlled Drug prescription forms webpage).
  2. Consider staff availability. It is likely that many schools and childcare settings will close, affecting childcare arrangements.
  3. Inform their local NHS England team if they are planning to remain open and, if appropriate, liaise with their LPC to help NHS England ensure sufficient pharmaceutical services provision in all areas.
  4. If appropriate, liaise with other contractors in the area, in the public interest, to seek to ensure pharmaceutical services provision is adequate. There is a need to ensure that some pharmacies are open in each area.
  5. Note that if NHS England is considering issuing directions requiring a pharmacy to open, it is only likely to do so if the contractor agrees to open. Time is too short for the usual administrative process.
  6. Update the Directory of Services (DoS) entry and NHS website entry for the pharmacy, if relevant, to ensure it provides accurate information of the pharmacy’s opening times for the day. This is important to ensure, for example, that patients are only referred to the pharmacy through the Community Pharmacy Consultation Service (CPCS) when it is open. Updating DoS should be done as soon as practicable, to give time to make the change in NHS Profile Manager, to overcome any registration or technical issues, and for revised entries to be updated on the system. Please see our recent reminder for more information on how to update DoS and the NHS Website.
  7. Inform patients and the public of the nearest open pharmacy. If closed for the day, or for some of the day, ensure that relevant information on other pharmacies open in the area is available.

“The basic Terms of Service provision is that contractors are not required to open community pharmacies on Bank Holidays and, therefore, may choose to close for the 19th of September, or for the time of the state funeral. The Terms of Service provide that a pharmacy’s usual opening hours for that day will count towards its core contractual hours for the week,” said PSNC.

"It is envisaged that as with other issues, contractors will work with NHS England to ensure that patients’ needs are met."

More For You

NHS app to boost clinical trials

The focus is on encouraging people from underrepresented groups, including minorities from African and Asian heritage, to sign up for clinical trials.

iStock

Government to use NHS app to boost clinical trials

The government’s 10-Year Health Plan is expected to provide a fillip to clinical trials, and it plans to make use of the NHS App to encourage people to sign up as participants.

People will be able to sign up for the NIHR Be Part of Research service (bepartofresearch.uk) on the NHS App for the trials best suited to their interests and needs.

Keep ReadingShow less
US pharma bets big on China to snap up potential blockbuster drugs

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies

US pharma bets big on China to snap up potential blockbuster drugs

US drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData provided exclusively to Reuters.

Keep ReadingShow less
Alliance Healthcare team raises thousands with charity bike ride to Paris

The Alliance Healthcare team

Alliance Healthcare team raises thousands with charity bike ride to Paris

Eight Alliance Healthcare team members raised over £55,000 for Theodora Children’s Charity by cycling from Surrey to Paris.

From June 13th-15th, the team took on the gruelling 300 mile cross-border Tour D’Alliance 2025 challenge and raised vital funds to support children who may be living with serious health challenges through Theodora Children’s Charity’s Giggle Doctor programme.

Keep ReadingShow less
Over four million flu vaccines across England in the 2024/25 winter flu season.

Over four million flu vaccines across England in the 2024/25 winter flu season.

CCA release

Community pharmacy administered over four million flu vaccines

Community pharmacy administered over four million flu vaccines across England in the 2024/25 winter flu season, the highest outside of the pandemic, according to the Company Chemists’ Association.

This is nearly 10 per cent higher than the number of flu vaccines administered in 2023/24.

Keep ReadingShow less
Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less